Tracking <i>clusterin</i> expression in hematopoietic stem cells reveals their heterogeneous composition across the life span
Hematopoietic stem cells (HSCs) exhibit significant age-related phenotypic and functional alterations. Although single-cell technologies have elucidated age-related compositional changes, prospective identification of aging-associated HSC subsets has remained challenging. In this study, using clusterin (Clu)-green fluorescent protein (GFP) reporter mice, we demonstrated that Clu expression faithfully marks age-associated myeloid/platelet-biased HSCs throughout life. Clu-GFP expression clearly segregates a novel age-associated HSC subset that overlaps with but is distinct from those previously identified using antibodies against aging maker proteins or reporter systems of aged HSC signature genes. Clu-positive (Clu+) HSCs emerge as a minor population in the fetus and progressively expand with age. Clu+ HSCs display not only an increased propensity for myeloid/platelet-biased differentiation but also a unique behavior in the bone marrow, favoring self-renewal over differentiation into downstream progenitors. In contrast, Clu-negative (Clu-) HSCs exhibit lineage-balanced differentiation, which predominates in the HSC pool during development but becomes underrepresented as aging progresses. Both subsets maintain long-term self-renewal capabilities even in aged mice but contribute differently to hematopoiesis. The predominant expansion of Clu+ HSCs largely drives the age-related changes observed in the HSC pool. Conversely, Clu- HSCs preserve youthful functionality and molecular characteristics into old age. Consequently, progressive changes in the balance between Clu+ and Clu- HSC subsets account for HSC aging. Our findings establish Clu as a novel marker for identifying aging-associated changes in HSCs and provide a new approach that enables lifelong tracking of the HSC aging process.
Authors
- Yaeko Nakajima-Takagi
- Bahityar Rahmutulla (ORCID: https://orcid.org/0000-0002-4014-2789)
- Masayuki Yamashita (ORCID: https://orcid.org/0000-0001-9459-4329)
- Kazuaki Yokoyama (ORCID: https://orcid.org/0000-0002-2556-3833)
- Ola Rizq
- Atsushi Iwama (ORCID: https://orcid.org/0000-0001-9410-8992)
- Claus Nerlov (ORCID: https://orcid.org/0000-0002-0544-735X)
- Fumihito Miura (ORCID: https://orcid.org/0000-0003-2656-486X)
- N Yusa (ORCID: https://orcid.org/0009-0000-7801-0549)
- Akira Nishiyama (ORCID: https://orcid.org/0000-0002-8802-3770)
- Zhiqian Zheng (ORCID: https://orcid.org/0009-0007-3723-9727)
- Yuta Yamada (ORCID: https://orcid.org/0000-0002-9698-4301)
- Takashi Ito (ORCID: https://orcid.org/0000-0001-6097-2803)
- Takahiro Kamiya (ORCID: https://orcid.org/0000-0003-3080-3747)
- Shuhei Koide
- Atsushi Kaneda (ORCID: https://orcid.org/0000-0002-6980-5515)
- Motohiko Oshima (ORCID: https://orcid.org/0000-0001-6991-815X)
- Koichi Murakami
- Seiya Imoto (ORCID: https://orcid.org/0000-0002-2989-308X)
- Zi‐Kui Liu (ORCID: https://orcid.org/0000-0003-3346-3696)
- Tomohiko Tamura (ORCID: https://orcid.org/0000-0002-9664-1747)
Institutions
- St. Jude Children's Research Hospital (US)
- Kyushu University (JP)
- Chiba University (JP)
- Yokohama City University Medical Center (JP)
- University of Oxford (GB)
- Tokyo Medical University Hospital (JP)
- University of Tokyo Hospital (JP)
- MRC Weatherall Institute of Molecular Medicine (GB)
- MRC Human Immunology Unit (GB)
- Anglo-Norman Text Society (GB)
- The University of Tokyo (JP)
- Yokohama City University (JP)
Publication Details
- Journal
- Blood
- Published
- 2025-03-26
- DOI
- https://doi.org/10.1182/blood.2024025776
- Citations
- 6
- Primary Topic
- Clusterin in disease pathology
- Type
- article
- Field-Weighted Citation Impact
- 6.27